Gene therapy company Prevail raises $50M series B

Gene therapy company Prevail raises $50M series B

Submitted by admin on March 27, 2019 - 11:39pm
Source: 
BioCentury
News Tags: 
Prevail Therapeutics
gene therapy
neurodegenerative disease
Headline: 
Gene therapy company Prevail raises $50M series B
snippet: 

Prevail raised $50 million in a series B round to advance its pipeline of gene therapies for neurodegenerative diseases.

Do Not Allow Advertisers to Use My Personal information